NORTHWEST BIOTHERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Northwest Biotherapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2010 to Q3 2024.
  • Northwest Biotherapeutics Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 1.26M shares, a 10.9% increase year-over-year.
  • Northwest Biotherapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.12M shares, a 10.2% increase from 2022.
  • Northwest Biotherapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.02M shares, a 16.3% increase from 2021.
  • Northwest Biotherapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 874K shares, a 20.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.26M +124K +10.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 1.21M +106K +9.55% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 1.19M +113K +10.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 1.12M +103K +10.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 1.13M +93.4K +8.97% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 1.11M +104K +10.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 1.07M +116K +12.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 1.02M +142K +16.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 1.04M +165K +18.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 1M +152K +17.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 959K +125K +14.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 874K +148K +20.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 876K +128K +17.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 852K +154K +22.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 835K +194K +30.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 725K +161K +28.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 748K +171K +29.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 698K +147K +26.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 640K +111K +21% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 564K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 577K +116K +25.2% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 550K +125K +29.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 529K Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-24
Q3 2018 461K -281M -99.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 425K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q3 2017 281M +167M +145% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q3 2016 115M +36.8M +47.1% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q3 2015 78.1M +17.5M +28.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q3 2014 60.6M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q3 2012 11K +5.08K +85.5% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-14
Q1 2012 154M +76.5M +99.2% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-21
Q3 2011 5.95K -70.4M -100% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q1 2011 77.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 70.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.